BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sjöberg E, Meyrath M, Chevigné A, Östman A, Augsten M, Szpakowska M. The diverse and complex roles of atypical chemokine receptors in cancer: From molecular biology to clinical relevance and therapy. Adv Cancer Res 2020;145:99-138. [PMID: 32089166 DOI: 10.1016/bs.acr.2019.12.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 D'Uonnolo G, Reynders N, Meyrath M, Abboud D, Uchański T, Laeremans T, Volkman BF, Janji B, Hanson J, Szpakowska M, Chevigné A. The Extended N-Terminal Domain Confers Atypical Chemokine Receptor Properties to CXCR3-B. Front Immunol 2022;13:868579. [PMID: 35720349 DOI: 10.3389/fimmu.2022.868579] [Reference Citation Analysis]
2 Yang H, Shen Z, Luo L, Gao J, Chen S, Che J, Xu L, Wu M, Dong X. Molecular dynamics insights into the selectivity toward CXCR1 and CXCR2 antagonists. Chemical Physics Letters 2022;795:139539. [DOI: 10.1016/j.cplett.2022.139539] [Reference Citation Analysis]
3 Isci D, D'Uonnolo G, Wantz M, Rogister B, Lombard A, Chevigné A, Szpakowska M, Neirinckx V. Patient-Oriented Perspective on Chemokine Receptor Expression and Function in Glioma. Cancers (Basel) 2021;14:130. [PMID: 35008294 DOI: 10.3390/cancers14010130] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Wierzbicki J, Lipiński A, Bednarz-Misa I, Lewandowski Ł, Neubauer K, Lewandowska P, Krzystek-Korpacka M. Monocyte Chemotactic Proteins (MCP) in Colorectal Adenomas Are Differently Expressed at the Transcriptional and Protein Levels: Implications for Colorectal Cancer Prevention. J Clin Med 2021;10:5559. [PMID: 34884259 DOI: 10.3390/jcm10235559] [Reference Citation Analysis]
5 Al Delbany D, Robert V, Dubois-Vedrenne I, Del Prete A, Vernimmen M, Radi A, Lefort A, Libert F, Wittamer V, Sozzani S, Parmentier M. Expression of CCRL2 Inhibits Tumor Growth by Concentrating Chemerin and Inhibiting Neoangiogenesis. Cancers (Basel) 2021;13:5000. [PMID: 34638484 DOI: 10.3390/cancers13195000] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
6 Palmer CB, Meyrath M, Canals M, Kostenis E, Chevigné A, Szpakowska M. Atypical opioid receptors: unconventional biology and therapeutic opportunities. Pharmacol Ther 2021;:108014. [PMID: 34624426 DOI: 10.1016/j.pharmthera.2021.108014] [Reference Citation Analysis]
7 Singh AJ, Gray JW. Chemokine signaling in cancer-stroma communications. J Cell Commun Signal 2021;15:361-81. [PMID: 34086259 DOI: 10.1007/s12079-021-00621-7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Chevigné A, Janji B, Meyrath M, Reynders N, D'Uonnolo G, Uchański T, Xiao M, Berchem G, Ollert M, Kwon YJ, Noman MZ, Szpakowska M. CXCL10 Is an Agonist of the CC Family Chemokine Scavenger Receptor ACKR2/D6. Cancers (Basel) 2021;13:1054. [PMID: 33801414 DOI: 10.3390/cancers13051054] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
9 Lewandowska P, Wierzbicki J, Zawadzki M, Agrawal A, Krzystek-Korpacka M. Biphasic Expression of Atypical Chemokine Receptor (ACKR) 2 and ACKR4 in Colorectal Neoplasms in Association with Histopathological Findings. Biomolecules 2020;11:E8. [PMID: 33374792 DOI: 10.3390/biom11010008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
10 Arianfar E, Shahgordi S, Memarian A. Natural Killer Cell Defects in Breast Cancer: A Key Pathway for Tumor Evasion. Int Rev Immunol 2021;40:197-216. [PMID: 33258393 DOI: 10.1080/08830185.2020.1845670] [Reference Citation Analysis]
11 Liu H, Cheng Q, Xu DS, Wang W, Fang Z, Xue DD, Zheng Y, Chang AH, Lei YJ. Overexpression of CXCR7 accelerates tumor growth and metastasis of lung cancer cells. Respir Res 2020;21:287. [PMID: 33129326 DOI: 10.1186/s12931-020-01518-6] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
12 Meyrath M, Reynders N, Uchański T, Chevigné A, Szpakowska M. Systematic reassessment of chemokine-receptor pairings confirms CCL20 but not CXCL13 and extends the spectrum of ACKR4 agonists to CCL22. J Leukoc Biol 2021;109:373-6. [PMID: 32480426 DOI: 10.1002/JLB.2AB0520-275R] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]